comprehensive -WSS

comprehensive

author：fashion 2025-09-29 20:52:05 - browse：3723

Adobe

The federal government inappropriately lowered the 2024 Medicare Advantage star ratings of SCAN Health Plan, which led to the health insurance company in California losing hundreds of millions of dollars in bonuses from the government, a judge ruled Monday.

The decision will lead to more than $250 million funneling back into SCAN, which covers 270,000 Medicare Advantage enrollees. And it opens the door for other Medicare Advantage plans to potentially recoup huge sums of taxpayer-funded bonuses — even though many independent experts believe the quality rating system is flawed and doesn’t appropriately gauge quality of care for older adults and people with disabilities.

The Centers for Medicare and Medicaid Services, the federal agency that oversees all Medicare programs, said it does not comment on litigation. In an interview, SCAN CEO Sachin Jain told STAT that if the company had not gotten its expected bonus money, it would have had to shave benefits and reduce what it pays hospitals and doctors.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： 5 ways to address the shortage of health care workers

focus

WSS

White House announces new plan to address the growing threat of xylazine in overdose crisis

Using force crossed my mind when examining a defiant young patient

Teachers share how revamped forgiveness program helped with their student loans

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Judge agrees to delay next hearing in Trump classified documents case

5 ways to address the shortage of health care workers

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

explore

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Swim instructor mom warns parents not to buy blue swimsuits for kids

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Wisconsin governor employs partial veto to fund schools for 4 centuries

In age of alternative facts, a scholarly course on calling out crap

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Hollywood unions extend contract negotiations for actors

CDC panel: People 65 and older should get a Covid spring booster shot

Psychedelics group wrestles with new pharma identity

Bank of America ordered to pay more than $100 million for double charging fees, withholding rewards

focus

Pfizer is about to make a big push in cancer. Will investors listen?

Biden targets hefty hospital 'facility fees' that often surprise patients

Change Healthcare cyberattack shows risk of industry consolidation

CDC advisory group OKs chikungunya vaccine

The U.S. needs a new definition of substance use “recovery”

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

hotspot

focus

focus

focus